26 Sep, 2023 CereVasc eShunt® System Study Data Presented at Congress of Neurological Surgeons Meeting Admin2023-11-06T22:49:34+00:00September 26th, 2023| Read More
18 Sep, 2023 CereVasc Receives FDA IDE Approval to Expand its Clinical Study of Patients with Normal Pressure Hydrocephalus Utilizing the Generation 2 eShunt® System Admin2023-11-06T22:46:27+00:00September 18th, 2023| Read More
13 Sep, 2023 CereVasc eShunt® System Study Data Presented at the European Society of Minimally Invasive Neurological Therapy (ESMINT) Congress in Marseille Admin2023-11-06T22:43:59+00:00September 13th, 2023| Read More
